Global Infectious Disease Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Infectious Disease Therapeutics Market Size 2017-2028

2.1.2 Infectious Disease Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Infectious Disease Therapeutics Segment by Type

2.2.1 Drugs

2.2.2 Vaccines

2.3 Infectious Disease Therapeutics Market Size by Type

2.3.1 Infectious Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Infectious Disease Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Infectious Disease Therapeutics Segment by Application

2.4.1 HIV/AIDS

2.4.2 Influenza

2.4.3 Hepatitis

2.4.4 Malaria

2.4.5 Tuberculosis

2.4.6 Others

2.5 Infectious Disease Therapeutics Market Size by Application

2.5.1 Infectious Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Infectious Disease Therapeutics Market Size Market Share by Application (2017-2022)

3 Infectious Disease Therapeutics Market Size by Player

3.1 Infectious Disease Therapeutics Market Size Market Share by Players

3.1.1 Global Infectious Disease Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Infectious Disease Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Infectious Disease Therapeutics by Regions

4.1 Infectious Disease Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Infectious Disease Therapeutics Market Size Growth (2017-2022)

4.3 APAC Infectious Disease Therapeutics Market Size Growth (2017-2022)

4.4 Europe Infectious Disease Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Infectious Disease Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Infectious Disease Therapeutics Market Size by Country (2017-2022)

5.2 Americas Infectious Disease Therapeutics Market Size by Type (2017-2022)

5.3 Americas Infectious Disease Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Infectious Disease Therapeutics Market Size by Region (2017-2022)

6.2 APAC Infectious Disease Therapeutics Market Size by Type (2017-2022)

6.3 APAC Infectious Disease Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Infectious Disease Therapeutics by Country (2017-2022)

7.2 Europe Infectious Disease Therapeutics Market Size by Type (2017-2022)

7.3 Europe Infectious Disease Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Infectious Disease Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Infectious Disease Therapeutics Market Forecast

10.1 Global Infectious Disease Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Infectious Disease Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Infectious Disease Therapeutics Forecast

10.1.3 APAC Infectious Disease Therapeutics Forecast

10.1.4 Europe Infectious Disease Therapeutics Forecast

10.1.5 Middle East & Africa Infectious Disease Therapeutics Forecast

10.2 Americas Infectious Disease Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Infectious Disease Therapeutics Market Forecast

10.2.2 Canada Infectious Disease Therapeutics Market Forecast

10.2.3 Mexico Infectious Disease Therapeutics Market Forecast

10.2.4 Brazil Infectious Disease Therapeutics Market Forecast

10.3 APAC Infectious Disease Therapeutics Forecast by Region (2023-2028)

10.3.1 China Infectious Disease Therapeutics Market Forecast

10.3.2 Japan Infectious Disease Therapeutics Market Forecast

10.3.3 Korea Infectious Disease Therapeutics Market Forecast

10.3.4 Southeast Asia Infectious Disease Therapeutics Market Forecast

10.3.5 India Infectious Disease Therapeutics Market Forecast

10.3.6 Australia Infectious Disease Therapeutics Market Forecast

10.4 Europe Infectious Disease Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Infectious Disease Therapeutics Market Forecast

10.4.2 France Infectious Disease Therapeutics Market Forecast

10.4.3 UK Infectious Disease Therapeutics Market Forecast

10.4.4 Italy Infectious Disease Therapeutics Market Forecast

10.4.5 Russia Infectious Disease Therapeutics Market Forecast

10.5 Middle East & Africa Infectious Disease Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Infectious Disease Therapeutics Market Forecast

10.5.2 South Africa Infectious Disease Therapeutics Market Forecast

10.5.3 Israel Infectious Disease Therapeutics Market Forecast

10.5.4 Turkey Infectious Disease Therapeutics Market Forecast

10.5.5 GCC Countries Infectious Disease Therapeutics Market Forecast

10.6 Global Infectious Disease Therapeutics Forecast by Type (2023-2028)

10.7 Global Infectious Disease Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis AG

11.1.1 Novartis AG Company Information

11.1.2 Novartis AG Infectious Disease Therapeutics Product Offered

11.1.3 Novartis AG Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis AG Main Business Overview

11.1.5 Novartis AG Latest Developments

11.2 Gilead

11.2.1 Gilead Company Information

11.2.2 Gilead Infectious Disease Therapeutics Product Offered

11.2.3 Gilead Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Gilead Main Business Overview

11.2.5 Gilead Latest Developments

11.3 GlaxoSmithKline plc

11.3.1 GlaxoSmithKline plc Company Information

11.3.2 GlaxoSmithKline plc Infectious Disease Therapeutics Product Offered

11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 GlaxoSmithKline plc Main Business Overview

11.3.5 GlaxoSmithKline plc Latest Developments

11.4 Janssen Pharmaceutical Inc.

11.4.1 Janssen Pharmaceutical Inc. Company Information

11.4.2 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product Offered

11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Janssen Pharmaceutical Inc. Main Business Overview

11.4.5 Janssen Pharmaceutical Inc. Latest Developments

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Information

11.5.2 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product Offered

11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview

11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments

11.6 BioCryst Pharmaceuticals Inc.

11.6.1 BioCryst Pharmaceuticals Inc. Company Information

11.6.2 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product Offered

11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 BioCryst Pharmaceuticals Inc. Main Business Overview

11.6.5 BioCryst Pharmaceuticals Inc. Latest Developments

11.7 Merck & Co. Inc.

11.7.1 Merck & Co. Inc. Company Information

11.7.2 Merck & Co. Inc. Infectious Disease Therapeutics Product Offered

11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck & Co. Inc. Main Business Overview

11.7.5 Merck & Co. Inc. Latest Developments

11.8 Boehringer Ingelheim GmbH

11.8.1 Boehringer Ingelheim GmbH Company Information

11.8.2 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product Offered

11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Boehringer Ingelheim GmbH Main Business Overview

11.8.5 Boehringer Ingelheim GmbH Latest Developments

12 Research Findings and Conclusion

Table 1. Infectious Disease Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Drugs

Table 3. Major Players of Vaccines

Table 4. Infectious Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Infectious Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Infectious Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 7. Infectious Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Infectious Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Infectious Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 10. Global Infectious Disease Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Infectious Disease Therapeutics Revenue Market Share by Player (2020-2022)

Table 12. Infectious Disease Therapeutics Key Players Head office and Products Offered

Table 13. Infectious Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Infectious Disease Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Infectious Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Infectious Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Infectious Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 20. Americas Infectious Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Infectious Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 22. Americas Infectious Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Infectious Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 24. APAC Infectious Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Infectious Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 26. APAC Infectious Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Infectious Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 28. APAC Infectious Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Infectious Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 30. Europe Infectious Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Infectious Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 32. Europe Infectious Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Infectious Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 34. Europe Infectious Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Infectious Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Infectious Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Infectious Disease Therapeutics

Table 43. Key Market Challenges & Risks of Infectious Disease Therapeutics

Table 44. Key Industry Trends of Infectious Disease Therapeutics

Table 45. Global Infectious Disease Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Infectious Disease Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Infectious Disease Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Infectious Disease Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Infectious Disease Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Infectious Disease Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 51. Novartis AG Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 52. Novartis AG Infectious Disease Therapeutics Product Offered

Table 53. Novartis AG Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Novartis AG Main Business

Table 55. Novartis AG Latest Developments

Table 56. Gilead Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 57. Gilead Infectious Disease Therapeutics Product Offered

Table 58. Gilead Main Business

Table 59. Gilead Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Gilead Latest Developments

Table 61. GlaxoSmithKline plc Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 62. GlaxoSmithKline plc Infectious Disease Therapeutics Product Offered

Table 63. GlaxoSmithKline plc Main Business

Table 64. GlaxoSmithKline plc Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. GlaxoSmithKline plc Latest Developments

Table 66. Janssen Pharmaceutical Inc. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 67. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product Offered

Table 68. Janssen Pharmaceutical Inc. Main Business

Table 69. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Janssen Pharmaceutical Inc. Latest Developments

Table 71. F. Hoffmann-La Roche Ltd. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 72. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product Offered

Table 73. F. Hoffmann-La Roche Ltd. Main Business

Table 74. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. F. Hoffmann-La Roche Ltd. Latest Developments

Table 76. BioCryst Pharmaceuticals Inc. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 77. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product Offered

Table 78. BioCryst Pharmaceuticals Inc. Main Business

Table 79. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. BioCryst Pharmaceuticals Inc. Latest Developments

Table 81. Merck & Co. Inc. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 82. Merck & Co. Inc. Infectious Disease Therapeutics Product Offered

Table 83. Merck & Co. Inc. Main Business

Table 84. Merck & Co. Inc. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Merck & Co. Inc. Latest Developments

Table 86. Boehringer Ingelheim GmbH Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors

Table 87. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product Offered

Table 88. Boehringer Ingelheim GmbH Main Business

Table 89. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Boehringer Ingelheim GmbH Latest Developments

List of Figures

Figure 1. Infectious Disease Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Infectious Disease Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Infectious Disease Therapeutics Market Size Market Share by Type in 2021

Figure 7. Infectious Disease Therapeutics in HIV/AIDS

Figure 8. Global Infectious Disease Therapeutics Market: HIV/AIDS (2017-2022) & ($ Millions)

Figure 9. Infectious Disease Therapeutics in Influenza

Figure 10. Global Infectious Disease Therapeutics Market: Influenza (2017-2022) & ($ Millions)

Figure 11. Infectious Disease Therapeutics in Hepatitis

Figure 12. Global Infectious Disease Therapeutics Market: Hepatitis (2017-2022) & ($ Millions)

Figure 13. Infectious Disease Therapeutics in Malaria

Figure 14. Global Infectious Disease Therapeutics Market: Malaria (2017-2022) & ($ Millions)

Figure 15. Infectious Disease Therapeutics in Tuberculosis

Figure 16. Global Infectious Disease Therapeutics Market: Tuberculosis (2017-2022) & ($ Millions)

Figure 17. Infectious Disease Therapeutics in Others

Figure 18. Global Infectious Disease Therapeutics Market: Others (2017-2022) & ($ Millions)

Figure 19. Global Infectious Disease Therapeutics Market Size Market Share by Application in 2021

Figure 20. Global Infectious Disease Therapeutics Revenue Market Share by Player in 2021

Figure 21. Global Infectious Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Infectious Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 23. APAC Infectious Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 24. Europe Infectious Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Infectious Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 26. Americas Infectious Disease Therapeutics Value Market Share by Country in 2021

Figure 27. Americas Infectious Disease Therapeutics Consumption Market Share by Type in 2021

Figure 28. Americas Infectious Disease Therapeutics Market Size Market Share by Application in 2021

Figure 29. United States Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Infectious Disease Therapeutics Market Size Market Share by Region in 2021

Figure 34. APAC Infectious Disease Therapeutics Market Size Market Share by Application in 2021

Figure 35. China Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Infectious Disease Therapeutics Market Size Market Share by Country in 2021

Figure 42. Europe Infectious Disease Therapeutics Market Size Market Share by Type in 2021

Figure 43. Europe Infectious Disease Therapeutics Market Size Market Share by Application in 2021

Figure 44. Germany Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Application in 2021

Figure 52. Egypt Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Infectious Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. APAC Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Europe Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. United States Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Canada Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. China Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Japan Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Korea Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. India Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Australia Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Germany Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. France Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. UK Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Italy Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. Russia Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 76. Spain Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 79. Israel Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Infectious Disease Therapeutics Market Size 2023-2028 ($ Millions)